Comparison of Vildagliptin and Pioglitazone in Korean Patients with Type 2 Diabetes Inadequately Controlled with Metformin.

Jong Ho KimSang Soo KimHong Sun BaekIn Kyu LeeDong Jin ChungHo Sang SohnHak Yeon BaeMi Kyung KimJeong Hyun ParkYoung Sik ChoiYoung Il KimJong Ryeal HahmChang Won LeeSung Rae JoMi Kyung ParkKwang Jae LeeIn-Joo Kim

Published in: Diabetes & metabolism journal (2016)

As an add-on to metformin, the efficacy of vildagliptin for the improvement of glycemic control is not inferior to that of pioglitazone in Korean patients with type 2 diabetes. In addition, add-on treatment with vildagliptin had beneficial effects on PPG levels, lipid profiles, and body weight compared to pioglitazone.

Keyphrases

body weight
glycemic control
type diabetes
blood glucose
weight loss
combination therapy
adipose tissue
skeletal muscle
replacement therapy